Cargando…
Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin
Cancer heterogeneity and microenvironmental aspects within a tumor are considered key factors influencing resistance of carcinoma cells to distinct chemotherapeutical agents. We evaluated a high concentration of metformin in combination with gemcitabine on a syngeneic orthotopic mouse model using 66...
Autores principales: | Zechner, Dietmar, Bürtin, Florian, Albert, Ann-Christin, Zhang, Xianbin, Kumstel, Simone, Schönrogge, Maria, Graffunder, Josefine, Shih, Hao-Yu, Müller, Sarah, Radecke, Tobias, Jaster, Robert, Vollmar, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302922/ https://www.ncbi.nlm.nih.gov/pubmed/27486761 http://dx.doi.org/10.18632/oncotarget.10892 |
Ejemplares similares
-
Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines
por: Zechner, Dietmar, et al.
Publicado: (2017) -
Analysis of Axin2 expression and function in murine models for pancreatic cancer
por: Zechner, Dietmar, et al.
Publicado: (2016) -
LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer
por: Zhang, Xianbin, et al.
Publicado: (2019) -
Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells
por: Zhang, Xianbin, et al.
Publicado: (2018) -
Impact of diabetes type II and chronic inflammation on pancreatic cancer
por: Zechner, Dietmar, et al.
Publicado: (2015)